SciCheck Digest Clinical trial data for Pfizer’s maternal vaccine to protect babies from RSV support the vaccine’s safety and efficacy, according to a vote by an FDA advisory committee. The FDA could soon approve the vaccine. But a popular social media post makes misleading claims about the trial findings. Full Story Respiratory syncytial virus, or […]

The post Instagram Post Misleads About Pfizer’s RSV Maternal Vaccine appeared first on The Atlanta Voice.